Despite worries that a new coronavirus variant may be able to evade vaccines just being distributed, a Harvard public health expert expressed confidence in the same technology that produced the vaccines in record time.

Will the British variant’s transmissibility upset summer plans?

Experts said the complex rollout of a coronavirus vaccine gives the U.S. a chance for a win after the virus gained the upper hand in its initial phase.

Barry Bloom from the Harvard T.H. Chan School of Public Health offers context about the news that two experimental vaccines appear to confer a high level of protection from the coronavirus.

A public campaign to build trust may be needed if a successful vaccine candidate is to be taken by enough Americans to interrupt the COVID pandemic, a Harvard public health expert said.

Rising nationalism and global inequity will be hurdles to the distribution of COVID vaccines, despite the comparatively “lightning” fast scientific response to the pandemic so far, a Harvard infectious disease expert said Thursday.